From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

Benefits of Antidepressants Appear to Outweigh Risks in Children and Adolescents

Slightly increased risk for suicidal ideation with antidepressant use, but even greater benefits

Previous analyses showing an increased risk for suicidal ideation in children and adolescents taking antidepressants led the FDA to require a boxed warning on labels of all antidepressants. To further assess the risks and benefits of antidepressants, researchers conducted a meta-analysis of 27 clinical trials of antidepressant use (mostly SSRIs) in pediatric patients for major depressive disorder (MDD, 15 trials), obsessive-compulsive disorder (OCD, 6 trials), and other anxiety disorders (6 trials).

In pooled analyses, response rates in the drug and placebo groups were 61% versus 50% for patients with MDD, 52% versus 32% for patients with OCD, and 69% versus 39% for patients with other anxiety disorders. After minor statistical adjustments, the numbers needed to treat to benefit one patient were 10, 6, and 3 for MDD, OCD, and other anxiety disorders, respectively. The absolute difference in risk for suicidal ideation between antidepressant and placebo groups was 0.7% (number needed to harm, 143). No completed suicides occurred in any trial.

Comment: These data provide a more balanced picture of the risks and benefits of antidepressant use in pediatric patients. The results support their use in children and adolescents by knowledgeable and experienced clinicians for appropriate diagnoses and with careful monitoring. The relatively greater efficacy in patients with anxiety disorders compared to those with MDD is worthy of further study.

— Thomas L. Schwenk, MD

Published in Journal Watch General Medicine May 1, 2007

Citation(s):

Bridge JA et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. JAMA 2007 Apr 18; 297:1683-96.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Related Content

Other Perspectives

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2007. Massachusetts Medical Society. All rights reserved.